| Myeloid Neoplasm studied in …STUDIED_INderived200 of 4,789show all (up to 200) |
|---|
| → studied in | NCT03418038Phase 2 · recruiting Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03494569Phase 1 · suspended Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03560752Phase 1 · active not recruiting CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04429191Phase 1 · completed JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation · condition mapped PROBABILISTIC · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05015426Phase 1 · active not recruiting Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05025488Phase 1 · active not recruiting Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554393Phase 2 · recruiting Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06303193Phase 1/Phase 2 · recruiting Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06484062Phase 1 · recruiting Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06651229Phase 1 · active not recruiting A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06904066Phase 1 · recruiting Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07437950Phase 2 · recruiting Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07722611Phase 2/Phase 3 · recruiting A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025) · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03629171Phase 2 · recruiting Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925479Phase 1/Phase 2 · recruiting Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Myeloid Leukemia, Philadelphia-Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05453903Phase 1 · active not recruiting A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05548062active not recruiting Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06236724Phase 2 · recruiting Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06317662Phase 2 · recruiting Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06401603Phase 1 · recruiting A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06548230Phase 1/Phase 2 · recruiting A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618001Phase 1 · active not recruiting A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788509Phase 1 · enrolling by invitation A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820268Phase 1 · recruiting A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06852222Phase 3 · recruiting A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07211958Phase 3 · recruiting Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07269470Phase 2 · recruiting Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07295951Phase 1 · completed A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07841002Phase 1 · not yet recruiting CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03661307Phase 1/Phase 2 · recruiting Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874052Phase 1 · recruiting Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04219163Phase 1 · active not recruiting Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05949125Phase 1 · recruiting Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies (1b Dose Expansion) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06071624Phase 1 · suspended Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML. · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06197672Phase 1 · suspended Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06398457early Phase 1 · recruiting Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714591Phase 1 · terminated Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1 · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06871410Phase 1 · recruiting Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07839858completed A Study of Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02392429Phase 2 · active not recruiting FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266795Phase 2 · completed A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04910685Phase 2/Phase 3 · recruiting (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05320198Phase 1/Phase 2 · recruiting Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05360160Phase 1/Phase 2 · recruiting A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05918692Phase 1 · completed A Phase 1 Study of BMF-500 in Adults With Acute Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014489Phase 2 · recruiting A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07012044Phase 1 · recruiting A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07504458Phase 3 · recruiting Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581002Phase 2/Phase 3 · recruiting A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03182244Phase 3 · completed A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839771Phase 3 · active not recruiting A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05035706early Phase 1 · active not recruiting Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05201066Phase 2 · active not recruiting Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554406Phase 2 · recruiting Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06058741completed A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06317649Phase 2 · recruiting Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06672146Phase 2 · recruiting Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06917911Phase 2 · recruiting Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Core Binding Factor Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07478991Phase 3 · recruiting Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI) · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07661095Phase 1 · recruiting A Study of CRD3874-SI in People With Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832513not yet recruiting Study of Pregnancy in Patients With Myeloproliferative Neoplasms · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07834918not yet recruiting Pulmonary Hypertension and RV Dysfunction in Myeloproliferative Neoplasms · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02782546Phase 2 · active not recruiting Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03588078Phase 1/Phase 2 · completed Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04935684Phase 2 · recruiting Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06379360Phase 2 · active not recruiting Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07346105available Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801489Phase 2 · recruiting Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530034Phase 1 · active not recruiting Hu8F4 in Treating Patients With Advanced Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03214562Phase 1/Phase 2 · recruiting Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03630991Phase 1 · recruiting Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04021368Phase 1 · terminated RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734990Phase 1/Phase 2 · active not recruiting Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Chronic Myelomonocytic Leukemia-0 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007873Phase 2 · active not recruiting ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06191263Phase 2 · recruiting Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06284486Phase 1/Phase 2 · recruiting A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06769490Phase 1 · recruiting Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06817720Phase 2 · recruiting Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07469891Phase 1 · recruiting A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828535Phase 1 · not yet recruiting Liposomal Mitoxantrone Plus Azacitidine and Venetoclax in Newly Diagnosed Elderly or Unfit AML · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282187Phase 2 · recruiting Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04293562Phase 3 · recruiting A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375631Phase 1 · recruiting CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05955261Phase 2 · recruiting A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06668558Phase 2 · active not recruiting Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06786533Phase 1 · recruiting Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06987058Phase 2 · enrolling by invitation RVU120 Rollover Study · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07094750NA · recruiting Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Myeloid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07645469Phase 1 · recruiting FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07825207active not recruiting Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07826897not yet recruiting Real-Time Breath Analysis in Acute Myeloid Leukaemia for a Rapid Characterisation of Biological Subtypes and to Predict Therapy Responses · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00044122recruiting Study of Factors Regulating Mast Cell Proliferation · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00900198recruiting Collection of Tissue Samples for Cancer Research · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746836Phase 2 · recruiting Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816319Phase 1 · active not recruiting TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04065399Phase 1/Phase 2 · recruiting A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04657081Phase 1/Phase 2 · active not recruiting Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05786924Phase 1/Phase 2 · recruiting Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05807932Phase 1/Phase 2 · recruiting Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06226571Phase 1 · active not recruiting A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06268574Phase 2 · terminated Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06345027Phase 1 · recruiting Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY) · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06397313Phase 2 · terminated RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06504459Phase 2 · recruiting Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Monocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06824168Phase 2 · recruiting Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822789active not recruiting Chidamide in HR-AML · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03516279Phase 2 · active not recruiting Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03849651Phase 2 · active not recruiting TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996875Phase 2 · recruiting (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Malignant Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06421155NA · suspended Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06423911Phase 3 · recruiting Study of Olverembatinib (HQP1351) in Patients With CML-CP · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06810583Phase 1 · recruiting A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06904482Phase 2 · recruiting Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07588594NA · recruiting Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07723703Phase 1 · recruiting Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07785180recruiting A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00435864NA · completed Natural Killer Index From Hematopoietic Stem Cell Graft · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00863148Phase 2 · completed Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01188174Phase 2 · completed Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01541280Phase 2 · completed VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530463Phase 2 · active not recruiting Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689440Phase 2 · active not recruiting Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03471260Phase 1/Phase 2 · recruiting Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03683433Phase 2 · recruiting Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Bilineal Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04128501Phase 2 · active not recruiting Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Bilineal Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216524Phase 2 · recruiting Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04547062Phase 1 · completed Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771130Phase 1/Phase 2 · recruiting A Study of BGB-11417 in Participants With Myeloid Malignancies · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06765876early Phase 1 · active not recruiting CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06846606Phase 1 · recruiting Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831635completed Myeloproliferative Neoplasms: an In-depth Case-control Study · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01861314Phase 1 · active not recruiting Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02938858completed French Registry of First-line Treatment of Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05520567Phase 1/Phase 2 · active not recruiting A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05641259Phase 1 · recruiting A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05875805NA · recruiting A Telehealth Advance Care Planning Intervention · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05884333Phase 2 · recruiting Cord Blood Transplant in Adults With Blood Cancers · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06566742Phase 2 · recruiting A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia. · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06597734Phase 2 · withdrawn A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06616636Phase 1 · recruiting A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06956755recruiting Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06969430Phase 1/Phase 2 · recruiting A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07044687Phase 4 · recruiting Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07616921NA · recruiting A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07676006early Phase 1 · not yet recruiting A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814560not yet recruiting Metabolic Syndrome and Risk of Chronic Philadelphia Negative Myeloproliferative Neoplasms · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03953898Phase 2 · active not recruiting Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04940468NA · completed High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05589896Phase 1/Phase 2 · active not recruiting A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06680661Phase 2 · suspended ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06704152Phase 1/Phase 2 · terminated BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255872Phase 2/Phase 3 · recruiting A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07566585Phase 1 · withdrawn Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07605949Phase 2 · not yet recruiting Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623187Phase 2/Phase 3 · not yet recruiting A Study to Assess How Well the Study Medicine IPN60340 Works in Combination With Azacitidine and Venetoclax, Compared to Placebo in Combination With Azacitidine and Venetoclax, in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Cannot Receive Intensive Chemotherapy · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07710781NA · not yet recruiting Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07813390Phase 2 · enrolling by invitation Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814170NA · active not recruiting A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In Greece · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814339Phase 1 · not yet recruiting Hydrochloroquinine & Decitabine With Venetoclax in AML · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01522976Phase 2 · active not recruiting Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890329Phase 1 · active not recruiting Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04049539Phase 1/Phase 2 · recruiting Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04227847Phase 1 · active not recruiting A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04628026Phase 3 · recruiting Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2 · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06073730Phase 3 · completed Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235801Phase 1/Phase 2 · recruiting A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06429098Phase 2 · active not recruiting Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06439199recruiting Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06888323Phase 1 · suspended Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06954987Phase 2 · not yet recruiting Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062250NA · completed Feasibility and Safety of Home Blood Count Measurement and Transfusions in Patients With Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153497Phase 2 · not yet recruiting Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07306832Phase 1 · recruiting A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07384715Phase 1 · recruiting First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796620Phase 1/Phase 2 · not yet recruiting Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNI · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07809984NA · not yet recruiting Prevention of Oral Mucositis in Adults in With Hematologic Malignancy · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07810829not yet recruiting Prognostic Value of CAR, AFR and Ferritin in Non-M3 AML · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04269213Phase 2 · completed CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07429266Phase 3 · recruiting INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV) · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03383575Phase 2 · recruiting Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03386513Phase 1/Phase 2 · active not recruiting Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04655755Phase 1/Phase 2 · active not recruiting Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04746235Phase 2 · active not recruiting Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05010122Phase 1/Phase 2 · recruiting ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05849662Phase 1/Phase 2 · recruiting A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06191978Phase 1 · recruiting A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07022678Phase 3 · recruiting Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07264959recruiting An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM) · condition mapped ONTOLOGY_EXACT · 4,789 trials mapped (1,328 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07804901Phase 2 · not yet recruiting Asciminib Frontline Risk Adapted · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07805746not yet recruiting Peri-graft Cytokine Profile: Influence of Hematologic Disease and Donor Type · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03013998Phase 2/Phase 3 · recruiting Study of Biomarker-Based Treatment of Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03459534Phase 3 · recruiting A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03722420Phase 3 · active not recruiting Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China) · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04635384active not recruiting Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test · condition mapped CURATED_BROADER · 4,789 trials mapped (1,328 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05282459Phase 1/Phase 2 · completed Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation · condition mapped ALIAS · 4,789 trials mapped (1,328 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |